MNOV

1.38

0.00% 0.00

Handel nachbörslich: 1.33 -0.05 -3.62%

Medicinova Inc (MNOV)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose Aktiensplit

Schlusskurs vom Vortag:

$1.38

Offen:

$1.41

24-Stunden-Volumen:

22,707

Relative Volume:

0.03

Marktkapitalisierung:

$67.82M

Einnahmen:

$134.60K

Nettoeinkommen (Verlust:

$-11.81M

KGV:

-5.7285

EPS:

-0.2409

Netto-Cashflow:

$-10.05M

1W Leistung:

+6.98%

1M Leistung:

-11.54%

6M Leistung:

+10.40%

1J Leistung:

-36.11%

1-Tages-Spanne:

$1.38

$1.41

1-Wochen-Bereich:

$1.28

$1.41

52-Wochen-Spanne:

$1.13

$2.15

Medicinova Inc Stock (MNOV) Company Profile

Firmenname

Medicinova Inc

Sektor

Healthcare (1114)

Branche

Biotechnology (625)

Telefon

858-373-1500

Adresse

4275 EXECUTIVE SQUARE, LA JOLLA, CA

Mitarbeiter

Twitter

@MedicinovaJapan

Nächster Verdiensttermin

2025-08-15

Neueste SEC-Einreichungen

MNOV's Discussions on Twitter

Vergleichen Sie MNOV mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
MNOV Medicinova Inc	1.38	67.82M	134.60K	-11.81M	-10.05M	-0.2409
VRTX Vertex Pharmaceuticals Inc	468.38	113.87B	11.74B	3.68B	3.34B	14.19
REGN Regeneron Pharmaceuticals Inc	776.54	80.22B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	406.40	52.56B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	803.74	49.31B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	175.07	37.37B	447.02M	-1.18B	-906.14M	-6.1812

Medicinova Inc Stock (MNOV) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2021-03-10	Eingeleitet	Maxim Group	Buy
2019-03-25	Fortgesetzt	B. Riley FBR	Buy
2018-03-28	Eingeleitet	B. Riley FBR, Inc.	Buy
2017-04-18	Eingeleitet	Credit Suisse	Outperform
2013-01-04	Bestätigt	Ladenburg Thalmann	Buy
2012-05-24	Herabstufung	MLV & Co	Buy → Hold
2011-10-18	Bestätigt	MLV Capital	Buy
2011-06-22	Eingeleitet	Global Hunter Securities	Buy
2010-05-12	Eingeleitet	Wedbush	Outperform
2008-11-12	Bestätigt	Ladenburg Thalmann	Buy
2008-05-15	Eingeleitet	Rodman & Renshaw	Mkt Outperform
2007-07-09	Eingeleitet	Punk, Ziegel & Co	Buy

Alle ansehen

Medicinova Inc Aktie (MNOV) Neueste Nachrichten

Jan 06, 2026

MediciNova, Inc. Provides Shareholder Update on Clinical Trials and Strategic Developments for 2026 - Quiver Quantitative

Jan 06, 2026

2026 New Year’s Greetings from the CEO - Bluefield Daily Telegraph

Jan 06, 2026

MediciNova (NASDAQ:MNOV) Shares Cross Above Two Hundred Day Moving Average – What’s Next? - Defense World

Jan 06, 2026

Jan 02, 2026

MNOVProspectus Filed Pursuant to Rule 424(b)(5) (424b5) - ADVFN

Jan 02, 2026

Jan 01, 2026

Retail Trends: Is MediciNova Inc stock a top pick in earnings seasonWeekly Profit Recap & High Conviction Buy Zone Picks - moha.gov.vn

Jan 01, 2026

4875.T Jumps 8.7% Today: Positive Momentum in Biotech - Meyka

Jan 01, 2026

Dec 30, 2025

MediciNova enters $50 million equity distribution agreement with Lucid Capital - Investing.com Nigeria

Dec 30, 2025

MediciNova Inc enters $50 million equity distribution agreement with Lucid Capital Markets - marketscreener.com

Dec 30, 2025

Medicinova IncOn Dec 29, Entered $50 Million Equity Distribution Agreement With Lucid Capital Markets- SEC Filing - TradingView — Track All Markets

Dec 30, 2025

MediciNova Establishes Flexible At-The-Market Equity Program - TipRanks

Dec 30, 2025

MediciNova enters $50 million equity distribution agreement with Lucid Capital By Investing.com - Investing.com South Africa

Dec 30, 2025

MediciNova Signs Equity Distribution Agreement With Lucid Capital Markets - TradingView — Track All Markets

Dec 30, 2025

Form 424B5 MEDICINOVA INC - StreetInsider

Dec 30, 2025

Dec 28, 2025

MediciNova, Inc. (NASDAQ:MNOV) Sees Large Decline in Short Interest - MarketBeat

Dec 28, 2025

Dec 21, 2025

Bank Watch: Why MediciNova Inc. stock could benefit from AI revolutionTrade Analysis Report & AI Driven Stock Price Forecasts - moha.gov.vn

Dec 21, 2025

Dec 20, 2025

Is MediciNova Inc. stock a top pick in earnings seasonWeekly Investment Summary & Growth Focused Entry Point Reports - Bölüm Sonu Canavarı

Dec 20, 2025

Dec 19, 2025

Why MediciNova Inc. stock could benefit from AI revolutionQuarterly Portfolio Summary & Verified Technical Trade Signals - Улправда

Dec 19, 2025

Will MediciNova Inc. stock outperform value stocksDollar Strength & Real-Time Stock Movement Alerts - DonanımHaber

Dec 19, 2025

MediciNova (NASDAQ:MNOV) Receives Buy Rating from D. Boral Capital - Defense World

Dec 19, 2025

Dec 18, 2025

After-Hours Biotech Rally: Inspira, MediciNova, DiaMedica Therapeutics Among Gainers - Nasdaq

Dec 18, 2025

Aug Swings: Why MediciNova Inc. stock could benefit from AI revolution2025 Technical Overview & Verified Short-Term Plans - Улправда

Dec 18, 2025

D. Boral Capital Maintains MediciNova (MNOV) Buy Recommendation - Nasdaq

Dec 18, 2025

How MediciNova Inc. stock performs in rising dollar environmentEarnings Performance Report & Community Shared Stock Ideas - Улправда

Dec 18, 2025

MediciNova completes enrollment in chemotherapy neuropathy trial By Investing.com - Investing.com Nigeria

Dec 18, 2025

MNOV: Analyst Jason Kolbert Maintains 'Buy' Rating with $9 Price - GuruFocus

Dec 18, 2025

D. Boral Capital Reaffirms Buy Rating for MediciNova (NASDAQ:MNOV) - MarketBeat

Dec 18, 2025

MediciNova Completes Enrollment in a Phase 2 Study of Colorectal Cancer Drug - marketscreener.com

Dec 18, 2025

MediciNova completes enrollment in chemotherapy neuropathy trial - Investing.com India

Dec 18, 2025

MediciNova, Inc. Completes Patient Enrollment in Phase 2 OXTOX Study for MN-166 in Metastatic Colorectal Cancer Patients - Quiver Quantitative

Dec 18, 2025

MediciNova Announces Completion of Patient Enrollment - GlobeNewswire

Dec 18, 2025

Dec 16, 2025

Bank Watch: Will MediciNova Inc stock beat EPS estimatesJuly 2025 Breakouts & Community Driven Trade Alerts - moha.gov.vn

Dec 16, 2025

MediciNova (NASDAQ:MNOV) Stock Crosses Above 200-Day Moving Average – Here’s What Happened - Defense World

Dec 16, 2025

MediciNova (NASDAQ:MNOV) Stock Crosses Above 200-Day Moving AverageHere's What Happened - MarketBeat

Dec 16, 2025

Dec 11, 2025

Free cash flow per share of MediciNova, Inc. – TSE:4875 - TradingView — Track All Markets

Dec 11, 2025

Dec 10, 2025

MediciNova (NASDAQ:MNOV) Receives “Buy” Rating from D. Boral Capital - Defense World

Dec 10, 2025

Dec 08, 2025

MediciNova (MNOV) Analyst Rating Maintained at 'Buy' with $9.00 - GuruFocus

Dec 08, 2025

MediciNova completes enrollment in phase 2b/3 ALS clinical trial - Investing.com

Dec 08, 2025

MediciNova Provides Update on COMBAT-ALS Study of MN-166 for Amyotrophic Lateral Sclerosis - Quiver Quantitative

Dec 08, 2025

MediciNova Announces Update and Basic Characteristic Randomized Patients’ of Phase 2/3 Clinical Trial of MN-166 (Ibudilast) in ALS (COMBAT-ALS Clinical Trial) Presented at the 36th International Symposium on ALS/MND - The Manila Times

Dec 08, 2025

MediciNova completes enrollment in phase 2b/3 ALS clinical trial By Investing.com - Investing.com UK

Dec 08, 2025

MediciNova (NASDAQ: MNOV) fully enrolls 234-patient Phase 2b/3 ALS ALS trial, targets 2026 top-line data - Stock Titan

Dec 08, 2025

Dec 05, 2025

Is MediciNova Inc a good long term investmentTake Profit Strategies & Ride the Wave of Market-Beating Growth - earlytimes.in

Dec 05, 2025

Dec 04, 2025

Gainers Report: Can MediciNova Inc stock continue upward trendShare Buyback & Growth Focused Investment Plans - BỘ NỘI VỤ

Dec 04, 2025

Dec 03, 2025

Can MediciNova Inc. stock sustain free cash flow growthMarket Volume Report & Free Weekly Chart Analysis and Trade Guides - Newser

Dec 03, 2025

EBITDA per share of MediciNova, Inc. – TSE:4875 - TradingView

Dec 03, 2025

Can MediciNova Inc. stock continue upward trendJuly 2025 Price Swings & Verified Entry Point Signals - Newser

Dec 03, 2025

MediciNova (MNOV) Stock Analysis Report | Financials & Insights - Benzinga

Dec 03, 2025

Dec 02, 2025

MediciNova (NASDAQ:MNOV) Stock Crosses Above 200-Day Moving Average – Should You Sell? - Defense World

Dec 02, 2025

Dec 01, 2025